GNTX vs TVTX Comparison

Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue was about 89% of total revenue in 2025, down from 98% in 2024 due to the Voxx acquisition in April 2025. The company is constantly developing new applications for the technology to remain on top. Sales in 2025 totaled about $2.5 billion with 44.8 million mirrors shipped. The unit mix breaks out as 64% interior and 36% exterior versus 31% exterior in 2019. The company is based in Zeeland, Michigan.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.